Seeking Alpha
View as an RSS Feed

MedTechBio  

View MedTechBio's Comments BY TICKER:

Latest  |  Highest rated
  • Geron's Second-Line Myelofibrosis Trial Offers Significant EPS Potential [View article]
    I believed they paid $25,000 to keep yours, mine and other comments off the site. This happened fall of last year. I can't get a darned thing posted on that site. Pure evil. Can't wait until Imet is finally approved, though I'm sure the battle of good over evil won't be.
    Jul 28, 2015. 12:00 PM | 2 Likes Like |Link to Comment
  • Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment [View article]
    Oh boy Chinese stocks cliff diving towards the end of the session. Looks like the premier needs to make a few more phone calls and maybe drag someone out to the square.
    Jul 27, 2015. 07:11 AM | Likes Like |Link to Comment
  • Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment [View article]
    User I remember that, I guess they're not pursuing the short TL; at least not yet.
    Jul 27, 2015. 12:15 AM | Likes Like |Link to Comment
  • Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment [View article]
    Did we ever get an update on this trial?? NSCLC Imetelstat + Avastin.
    http://1.usa.gov/1IpcAQn
    Jul 26, 2015. 06:50 PM | Likes Like |Link to Comment
  • Geron's Second-Line Myelofibrosis Trial Offers Significant EPS Potential [View article]
    You sure it isn't bed bugs?
    Jul 26, 2015. 10:22 AM | 3 Likes Like |Link to Comment
  • Market Update: Current View Of The 'Secular Bull Market' Amidst The Backdrop Of Fear In The Markets, A View Of The Past, Present And Future [View article]
    I agree Jose (though I'm less sure about the "strong" part. More like range bound for awhile.
    Jul 26, 2015. 08:58 AM | 2 Likes Like |Link to Comment
  • Market Update: Current View Of The 'Secular Bull Market' Amidst The Backdrop Of Fear In The Markets, A View Of The Past, Present And Future [View article]
    Glenn you forgot about nuclear anihilation and Fukushima killing the Pacific ocean in its entirety.
    Jul 25, 2015. 07:06 PM | 1 Like Like |Link to Comment
  • Market Update: Current View Of The 'Secular Bull Market' Amidst The Backdrop Of Fear In The Markets, A View Of The Past, Present And Future [View article]
    "Every time the stock market has broken decisively above the top side of a 10+ years "range-bound" market, it has ALWAYS been the dawn of a new secular bull market. I maintain that this time is no different." ~ You

    "There are no relationships or equations that always work" ~ Barton Biggs


    Just havin' a little fun... :-)
    Jul 25, 2015. 10:56 AM | 12 Likes Like |Link to Comment
  • Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment [View article]
    I wonder if it is like successful businesses where the founders have become so rich, they are no longer watching the store.
    Jul 25, 2015. 08:39 AM | 1 Like Like |Link to Comment
  • Geron's Second-Line Myelofibrosis Trial Offers Significant EPS Potential [View article]
    That's still good for GERN, solidifies his position as leading oncology authority. Will be nice when he presents MDS at ASH.
    Jul 24, 2015. 03:51 PM | 1 Like Like |Link to Comment
  • Geron's Second-Line Myelofibrosis Trial Offers Significant EPS Potential [View article]
    They may approve it if you get the hives confirmed by doctor...maybe. Well documented India facilities (sorry don't mean to pick on them) have had manufacturing issues with generics like allergic reactions and not the right dosage, etc.
    Jul 24, 2015. 08:16 AM | 1 Like Like |Link to Comment
  • Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment [View article]
    What do you think of Ziopharm with MD Anderson and U. of Minn (genetics leader) backing. Not to mention the recent hires directly from MD Anderson.
    Jul 23, 2015. 03:13 PM | Likes Like |Link to Comment
  • Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment [View article]
    Shino, technically I agree. However, there would have to be a massive fraud on behalf of Mayo clinic data on a scale never before seen. This is more fine tuning treatment in my opinion.
    Jul 23, 2015. 01:17 PM | 2 Likes Like |Link to Comment
  • Geron's Second-Line Myelofibrosis Trial Offers Significant EPS Potential [View article]
    Janssen will have preliminary top-line data at the time of the conference. So very interesting!
    Jul 23, 2015. 02:10 AM | 3 Likes Like |Link to Comment
  • Allocation Advice For The Do-It-Yourself Investor [View article]
    I agree!!!
    Jul 23, 2015. 12:28 AM | Likes Like |Link to Comment
COMMENTS STATS
1,559 Comments
1,714 Likes